SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026084
Filing Date
2021-05-10
Accepted
2021-05-10 16:30:20
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lrmr-10q_20210331.htm 10-Q 1373901
2 EX-10.1 lrmr-ex101_148.htm EX-10.1 211813
3 EX-10.2 lrmr-ex102_147.htm EX-10.2 13953
4 EX-31.1 lrmr-ex311_7.htm EX-31.1 14739
5 EX-31.2 lrmr-ex312_8.htm EX-31.2 14714
6 EX-32.1 lrmr-ex321_6.htm EX-32.1 14180
7 GRAPHIC ggwh0kzcb0ho000001.jpg GRAPHIC 46235
  Complete submission text file 0001564590-21-026084.txt   6349055

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT lrmr-20210331.xml EX-101.INS 1331056
9 XBRL TAXONOMY EXTENSION SCHEMA lrmr-20210331.xsd EX-101.SCH 51296
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lrmr-20210331_cal.xml EX-101.CAL 49589
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lrmr-20210331_def.xml EX-101.DEF 144399
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE lrmr-20210331_lab.xml EX-101.LAB 399444
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lrmr-20210331_pre.xml EX-101.PRE 289222
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 21907671
SIC: 2834 Pharmaceutical Preparations